• SENSEX 79,212.53
    -588.90 (--0.74%)
  • BANKNIFTY 54,664.05
    -537.35 (--0.97%)
  • Apollo Hospitals
    6,900.70 5,690.80(%)
  • Waaree Energies
    2,590.20 1,808.65(%)
  • Reliance Industr
    1,288.00 1,115.55(%)
  • SpiceJet
    55.49 79.90(%)
  • Axis Bank
    1,145.75 934.00(%)
  • Dixon Technolog.
    16,092.55 7,935.00(%)
  • Suzlon Energy
    56.78 37.95(%)
  • Vodafone Idea
    7.44 6.60(%)
  • SBI Life Insuran
    1,763.00 1,935.00(%)
  • Tata Motors
    651.45 542.55(%)
  • Bharat Electron
    293.70 221.00(%)
  • Tata Power Co.
    382.00 326.25(%)
  • Reliance Power
    40.91 23.26(%)
  • Eternal Ltd
    226.95 146.85(%)
  • HDFC Bank
    1,891.90 1,430.15(%)
  • Jio Financial
    249.15 198.60(%)
  • Mazagon Dock
    2,585.00 1,046.00(%)
  • Adani Energy Sol
    907.00 588.25(%)
  • Nip. India Nifty
    266.61 242.12(%)
  • Adani Green
    904.00 758.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Suven Pharmaceuticals Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 74679.0
  • ISIN : INE03QK01018
1,143.20 -62 (-5.11%)
  • As on 26 Apr 2025 (EOD)

  • Today’s Low

    1,137.80

  • Today’s High

    1,219.50

  • Open

    1,208.00

  • Perv Close

    1,204.80

  • 52W Low

    598.00

  • 52W High

    1,360.00

Key Indicators

  • P/E(TTM)

    103.46

  • Mar.Cap (₹Cr.)

    29,101.87

  • Div & Yield %

    0.00

  • Book Value(₹)

    86.66

  • Debt-Equity Ratio

    -5.11

  • AGM Date

    25-Apr-2025

  • EPS

    11.05

  • P/E Ratio

    103.46

Financials Ratios

  • Debt-Equity Ratio

    0.04

  • Mar.Cap (₹Cr.)

    29,101.87

  • RONW (%)

    14.11

  • ROCE (%)

    18.69

Score Board

  • Equity (₹ in Cr.)

    25.46

  • BV (₹)

    86.70

  • Sales( ₹ in Cr.)

    1,024.99

  • NP (in Cr.)

    272.29

  • NP Var(%)

    -35.0

  • Div%

    0.0

  • CPS (₹)

    12.60

  • EPS (₹)

    10.70

  • Traded Value (₹ in Lakhs)

    29,103.14

  • 52 Week High

    1,360.00

  • 52 Week Low

    598.00

  • Price BSE

    1143.0

  • Price NSE

    1,143.00

  • Market Capital( in Cr.)

    29,103.14

  • P/C Ratio

    90.60

  • P/E Ratio

    106.90

  • Price Vs.BV

    10.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 1,024.99 1,330.08 1,320.22 1,009.72 833.79 377.83
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,024.99 1,330.08 1,320.22 1,009.72 833.79 377.83
Other Income 55.09 44.55 187.79 14.24 18.12 0.60
Stock Adjustments -53.88 20.94 60.35 8.37 11.05 21.32
Total Income 1,026.20 1,395.57 1,568.36 1,032.33 862.96 399.75
EXPENDITURE :            
Raw Materials 248.38 421.36 459.46 310.32 240.24 124.52
Power and Fuel Cost 46.16 71.35 59.55 44.20 38.24 18.06
Employee Cost 126.88 108.58 100.48 76.23 65.10 29.63
Other Manufacturing Expenses 83.19 101.96 115.25 90.76 66.49 33.83
Selling and Administration Expenses 38.85 43.57 52.38 44.93 44.72 16.23
Miscellaneous Expenses 17.75 13.50 11.17 8.61 5.26 5.34
Employee Benefit Expenses 126.88 108.58 100.48 76.23 65.10 29.63
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 561.21 760.33 798.29 575.05 460.05 227.60
Operating Profit 465.00 635.24 770.08 457.28 402.91 172.15
Interest 7.43 12.75 8.53 11.66 21.81 2.79
Gross Profit 457.57 622.49 761.55 445.62 381.10 169.36
Depreciation 48.79 43.10 39.10 31.64 23.51 11.50
Profit Before Tax 408.78 579.39 722.45 413.98 357.59 157.86
Current Tax 97.37 142.45 157.63 101.72 88.81 33.17
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 6.59 4.34 6.72 3.62 -1.30 15.42
Reported Net Profit 304.82 432.60 558.10 308.65 270.08 109.27
Extraordinary Items 32.53 10.55 14.53 2.51 4.73 0.11
Adjusted Net Profit 272.29 422.05 543.57 306.14 265.35 109.16
Adjustment below Net Profit -0.30 -0.26 -0.76 -0.84 -13.90 315.80
P & L Balance brought forward 1,490.07 1,276.39 835.88 568.52 390.98 0.00
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 218.65 116.83 40.46 78.64 34.09
P & L Balance carried down 1,794.59 1,490.07 1,276.39 835.88 568.52 390.98
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 600.00 500.00 200.00 500.00 0.00
Dividend Per Share(Rs) 0.00 6.00 5.00 2.00 5.00 0.00
Earnings Per Share-Unit Curr 11.97 16.99 21.92 12.12 21.22 20.60
Earnings Per Share(Adj)-Unit Curr 11.97 16.99 21.92 12.12 10.61 -
Book Value 80.76 68.72 59.74 41.84 61.50 0.00
Book Value(Adj)-Unit Curr 80.76 68.72 59.74 41.84 30.75 -

Shareholding Pattern

  • Promoter Group

    50.10%

  • Public Share Holding

    49.90%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 127,539,592 50.10 127,539,592 1
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 127,539,592 50.10 127,539,592 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 0 0.00 0 0
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 35,009 0.01 35,009 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 211 0.00 211 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 28,128,467 11.05 28,128,467 163
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 8,302,944 3.26 8,302,944 11
Mutual Funds / UTI 33,197,269 13.04 33,161,269 28
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 765,992 0.30 765,992 13
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 70,429,892 27.67 70,393,892 218
2] Non Institution
Bodies Corporate 28,331,006 11.13 28,327,006 743
Clearing Members 504 0.00 504 3
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 2,455,253 0.96 2,455,253 2,870
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 807,047 0.32 806,547 1,323
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 703,799 0.28 703,799 2
Individuals holding nominal share capital up to Rs. 1 lakh 23,941,220 9.40 23,609,149 81,155
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 8,005 0.00 8,005 9
Others 348,638 0.14 348,638 1
Sub Total 56,595,472 22.23 56,258,901 86,106
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 254,564,956 100.00 254,192,385 86,325

Company Background

Suven Pharmaceuticals LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Suven Pharmaceuticals Ltd
  • BSE Code : 74679.0
  • ISIN : INE03QK01018

  • Incorporation Year

    2018

  • Registered Office

    8-2-334 SDE Serene Chambers
    3 Floor Avenue 7 Road No 5, Hyderabad,
    Telangana-500034

  • Telephone

    91-40-23549414/1142/3311

  • FAX

    91-40-23541152

  • Chairman

    VIVEK SHARMA

  • Managing Director

    Venkatanaga Kali Vara Prasad Raju Vetukuri

  • Company Secretary

    Kundan Kumar Jha

  • Auditor

    Karvy & Co/Walker Chandiok & Co LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Suven Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Suven Pharma 1,143.25 1,080.09 1,024.99 103.46 18.82
Abbott India 29,747.90 6,097.18 5,848.91 47.37 44.71
Astrazeneca Phar 8,728.45 1,330.33 1,295.53 225.02 33.26
P & G Health Ltd 5,074.25 1,166.89 1,151.26 35.60 39.76
Glaxosmi. Pharma 2,804.05 3,530.73 3,407.25 55.76 44.44
Cipla 1,525.50 17,645.00 16,574.34 26.15 20.10
Amrutanjan Healt 656.65 437.58 421.23 38.49 20.84
Guj. Themis Bio. 283.70 174.19 169.82 58.74 44.82
Fermenta Biotec. 278.75 315.24 307.09 26.42 4.10
Bliss GVS Pharma 122.05 638.96 605.46 27.93 11.19
Ambalal Sarabhai 37.95 11.70 3.81 16.22 1.92